Clinical Context
A 58-year-old patient with type 2 diabetes mellitus presents for routine management and risk stratification. The clinician orders a laboratory panel that includes seven biochemical assays (such as hemoglobin A1c, fasting glucose, C-peptide, insulin, lipid markers, serum creatinine, and urinary albumin) processed by a clinical laboratory. The lab analyst performs the technical assays and inputs patient demographic and clinical data into a validated algorithmic analytic platform which calculates and reports a composite patient risk score for diabetes-related complications. Results are delivered to the ordering clinician and integrated into the electronic health record to inform longitudinal care planning and potential referral to endocrinology, nephrology, or cardiology.
Typical site of service: Clinical reference laboratory or hospital laboratory with a certified clinical laboratory improvement amendments (CLIA) waiver or appropriate CLIA certification. The specimen is collected in an outpatient clinic, physician office, or hospital outpatient phlebotomy service and shipped to the performing laboratory.
Typical patient scenario: An outpatient visit for diabetes follow-up where the clinician documents medication adherence concerns, recent weight change, and a need to stratify risk for microvascular and macrovascular complications. The clinician orders the composite biomarker panel with algorithmic analysis to guide intensity of monitoring and referrals. The laboratory performs the seven assays, runs the algorithm, and returns a calculated patient risk score with interpretive comments to the ordering provider.